Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

4.40
Delayed Data
As of 10:22am ET
 -0.0199 / -0.45%
Today’s Change
4.31
Today|||52-Week Range
15.95
-3.51%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization1.1K1.1K2.0K1.0K
 
 
 
 
 
 
Operating ExpensesGross Income-1.1K-1.1K-2.0K-1.0K
 
 
 
 
 
General Expenses1.2M1.9M1.7M1.9M
 
 
 
 
 
Research And Development673.3K1.1M858.0K1.3M
 
 
 
 
 
Total Operating Expenses1.2M1.9M1.7M1.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.2M-1.9M-1.7M-1.9M
 
 
 
 
 
Other Expenses-3.2K31.5K93.0K-5.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.1M-1.8M-1.6M-1.9M
 
 
 
 
 
Income Taxes0.000.00-4.0K0.00
 
 
Net Income-1.1M-1.8M-1.6M-1.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS9.1M9.9M10.1M10.1M
 
 
 
 
 
Shares To Calculate EPS Diluted9.1M9.9M10.1M10.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.12-$0.18---$0.19
 
 
 
 
EPS Diluted-$0.12-$0.18-$0.16-$0.19
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account